Anfield Energy Demonstrates the Economic Viability of its Velvet-Wood and Slick Rock Uranium and Vanadium Projects

Investing News NetworkYour trusted source for investing success

nasdaq ocul 2023

LATEST ARTICLES
Biotech Investing

Ocular Therapeutix Doses First Patient in Phase 3 Clinical Trial

Biotech Investing

Ocular Therapeutix™ Announces FDA Approval of Supplemental New Drug Application (sNDA) for DEXTENZA®

Company News

Ocular Therapeutix Announces Completion of Debt Refinancing

Pharmaceutical Investing

Ocular Therapeutix Announces NDA Resubmission of DEXTENZA

MARKETS

Markets
TSX19940.99+103.34
TSXV630.01+6.40
DOW32859.03+141.43
S&P 5004050.83+23.02
NASD12013.47+87.24
ASX7122.30+72.00

COMMODITIES

Commodities
Gold1979.41+1.02
Silver23.86-0.01
Copper4.07-0.02
Palladium1713.170.00
Platinum1087.260.00
Oil74.32-0.05
Heating Oil2.58+0.01
Natural Gas2.10-0.01

DOWNLOAD FREE REPORTS

EV Outlook 2023

2023 Lithium Outlook: Australia Edition

2023 Graphite Outlook: Australia Edition

2023 Battery Metals Outlook: Australia Edition

2023 Cobalt Outlook: Australia Edition

Browse more resource reports ≫

NEW! 2023 Tech Outlook Report

NEW! 2023 Cleantech Outlook Report

Emerging Tech Outlook 2023

NEW! 2023 AI Outlook Report

NEW! 2023 Crypto Outlook Report

Browse more technology reports ≫

NEW! 2023 Pharmaceuticals Outlook Report.

FREE 2023 Psychedelics Investor Report

NEW! 2023 Biotech Outlook Report.

NEW! 2023 Life Science Outlook Report.

Start Here – Investing in Pharma

Browse more life science reports ≫

BROWSE COMPANIES BY SECTOR

loader